ChemWerth becomes Exclusive Agent for Valacyclovir

Chongqing Fuan Pharmaceutical Co. Ltd. (Fuan) has chosen ChemWerth as their agent to distribute Valacyclovir. ChemWerth was chosen as their agent because of its regulatory expertise and experience in ensuring that the highest standards of the ICH, US FDA, USP and EP requirements are met.

Valacyclovir is used for the treatment of shingles (herpes zoster), cold sores and treating or suppressing genital herpes in patients with normal immune systems. It is also used to suppress genital herpes in patients with HIV infection. The territories covered under this agreement are the United States, Canada, European Community and the World Health Organization (WHO). In addition, this agreement will further ChemWerth’s goal to provide generic APIs at affordable prices to poor nations.

ChemWerth is a full service Generic Active Pharmaceutical Ingredient development and supply company specializing in oral, injectable, topical and veterinary products at competitive prices. Founded in 1982 to supply the emerging generic pharmaceutical industry with sources of reliable, high quality APIs, ChemWerth represents numerous FDA approved facilities in China, as well as a growing number of cGMP manufacturing facilities in the United States, Europe and India. For more information about the company please visit www.chemwerth.com.

<< Return to ChemWerth News